| Balance Sheets | 2026-03-31 | |||
|---|---|---|---|---|
| Cash | 280,275 | |||
| Other current assets | 2,600 | |||
| Total current assets | 282,875 | |||
| Deferred offering costs | 450,042 | |||
| Total assets | 732,917 | |||
| Accrued offering costs | 422,417 | |||
| Accrued offering costs related party | 10,500 | |||
| Accrued expenses | 40,249 | |||
| Promissory note sponsor | 300,000 | |||
| Total current liabilities | 773,166 | |||
| Common stock, value, issued-Common Class A | 0 | |||
| Common stock, value, issued-Common Class B | 132 | |||
| Additional paid-in-capital | 24,868 | |||
| Accumulated deficit | -65,249 | |||
| Total shareholders' deficit | -40,249 | |||
| Total liabilities and shareholders' deficit | 732,917 | |||
Research Alliance Corp III (RACC)
Research Alliance Corp III (RACC)